pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,475 catalysts · 5,159 phase readout · 2,327 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 32 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: pdufa×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,327
  • pdufa316
  • earnings275
  • phase 2 completion108
  • phase 1 completion50
phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06384352: Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

    Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07655947: Theory of Planned Behavior-Based Digital Addiction and Screen Time Management Training for Teachers

    Sponsor: Aydin Adnan Menderes University. Phase: NA. Conditions: Digital Addiction and Screen Time Management Among Teachers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07295847: A Study of AZD0120 in Autoimmune Diseases

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07603947: Impact of Forward Head Posture on Postural Stability and Gait Kinematics

    Sponsor: Cairo University. Phase: . Conditions: Forward Head Posture, Postural Stability, Gait Analysis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07371247: Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy

    Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: EARLY_PHASE1. Conditions: Esophageal Cancer, MRD, ctDNA

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01815749: Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

    Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03892148: Protocol of Diuretics Use in Congestive Therapy in Heart Failure

    Sponsor: University Hospital, Clermont-Ferrand. Phase: PHASE4. Conditions: Heart Failure, Acute Heart Failure, Chronic Heart Failure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07327255: Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant Women With Severe Pre-eclampsia

    Sponsor: Evergreen Therapeutics, Inc.. Phase: PHASE1. Conditions: Pre-eclampsia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03642626: MT2017-45: CAR-T Cell Therapy for Heme Malignancies

    Sponsor: Masonic Cancer Center, University of Minnesota. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia, Large B-cell Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07506278: Results Of Vivifrail Exercise In Older Type 2 Diabetic Patients With Fraity Syndrome

    Sponsor: National Geriatric Hospital. Phase: NA. Conditions: Type 2 Diabetes, Fraity Syndrome, Exercise Intervention

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07368478: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies

    Sponsor: Biocity Biopharmaceutics Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Malignancies

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06869785: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Relapsing Multiple Sclerosis (RMS)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07540585: MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients

    Sponsor: Indiana University. Phase: . Conditions: Anxiety Disorders, Stress Disorders, Post-Traumatic, Pregnancy, High Risk, Depressive Disorder, Major, Pregnancy Complications, ADHD - Attention Deficit Disorder With Hyperactivity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03979885: Financial Incentives for Smoking Treatment II

    Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Smoking Cessation, Tobacco Use Cessation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05813678: A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

    Sponsor: BioMarin Pharmaceutical. Phase: . Conditions: Phenylketonuria (PKU)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00720785: Natural Killer Cells and Bortezomib to Treat Cancer

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE1. Conditions: Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca, Multiple Myeloma, Carcinoma, Non-Small -Cell Lung

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04397185: Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer

    Sponsor: CairnSurgical, Inc.. Phase: NA. Conditions: Breast Cancer Female

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06834685: Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients

    Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: NA. Conditions: Cancer Survivors, Peripheral Neuropathic Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07416643: The Role of Incorporating Acacia Gum in Foods on Glucose Homeostasis in Healthy Humans

    Sponsor: King Abdulaziz University. Phase: NA. Conditions: Health Adult Subjects

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04684615: Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen

    Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Depression, Anxiety, Bipolar Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07263698: Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwash

    Sponsor: Colgate Palmolive. Phase: PHASE3. Conditions: Gingivitis, Plaque, Dental

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06800898: Orexin Gene in Anorexia Nervosa

    Sponsor: Istituto Auxologico Italiano. Phase: . Conditions: Anorexia Nervosa

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07634263: Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study

    Sponsor: Odense University Hospital. Phase: . Conditions: Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Multiple Myeloma Progression, Multiple Myeloma Refractory

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06700187: Frequency of Interrupting Sitting and Cognitive Function

    Sponsor: Maastricht University Medical Center. Phase: NA. Conditions: Sedentary Behaviors, Breaking Prolonged Sitting With Physical Activity

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07386587: Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

    Sponsor: University of Child Health Sciences and Children's Hospital, Lahore. Phase: PHASE3. Conditions: Juvenile Idiopathic Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07315087: CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis, IIM- Idiopathic Inflammatory Myopathies, ANCA Associated Vasculitis (AAV), Connective Tissue Disease-Associated Thrombocytopenia, SLE-ITP

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07600463: UVC in Prevention of Surgical Wound Infection

    Sponsor: Ville Leinonen. Phase: NA. Conditions: Hydrocephalus

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02777593: Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2

    Sponsor: W.L.Gore & Associates. Phase: NA. Conditions: Aortic Aneurysm, Thoracic, Aorta; Lesion

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05583721: Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

    Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Sickle Cell Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07646314: Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techniques inPiriformis Syndrome

    Sponsor: Riphah International University. Phase: NA. Conditions: Piriformis Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06308614: Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

    Sponsor: Estetra. Phase: PHASE2. Conditions: Sexual Dysfunction, Physiological

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05145816: Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

    Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE1. Conditions: AL Amyloidosis, Amyloidosis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04996316: MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

    Sponsor: OHSU Knight Cancer Institute. Phase: . Conditions: Breast Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05709106: A Prospective Real World Study of Rimegepant in the Treatment of Migraine

    Sponsor: Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine. Phase: . Conditions: Migraine

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05085704: Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease

    Sponsor: Weill Medical College of Cornell University. Phase: . Conditions: Glut1 Deficiency Syndrome 1, Glucose Metabolism Disorders, Epilepsy, Glut1 Deficiency Syndrome 1, Autosomal Recessive, Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter Protein Type 1 Deficiency Syndrome, Glucose Transport Defect

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07492433: Risk Factors, Incidence, and Clinical Impact of Intraluminal Thrombosis Following FET and TEVAR

    Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Phase: . Conditions: Intraluminal Thrombosis, Tevar, FET

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01417533: A Natural History Study of Patients With GNE Myopathy and GNE-Related Diseases

    Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: GNE Myopathy, GNE Related Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07401147: Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Labor.

    Sponsor: Ricardo A Gutierrez Ramirez, MD, MSc, FACOG. Phase: NA. Conditions: Labor Pain

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03373084: Imaging Location of Hamstring Muscle Lesions in Sport and Relationships With Injury Mechanism.

    Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: . Conditions: Sport Injury, Hamstring Muscle Lesions

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06776952: A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

    Sponsor: Evopoint Biosciences Inc.. Phase: PHASE3. Conditions: Relapsed/Refractory Peripheral T Cell Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05085249: Improving Goal Directed Medical Therapy for Device Clinic Patients With Reduced EF at UOHI: a QI Initiative (VIGILANT)

    Sponsor: Ottawa Heart Institute Research Corporation. Phase: . Conditions: Heart Failure

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06019949: Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury

    Sponsor: University of Louisville. Phase: NA. Conditions: Spinal Cord Injuries, Respiration Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05602038: Comparative Study on the Effect of Quadratus Lumborum Block Versus Intrathecal Morphine on the Incidence of Chronic Pain Post Caesarean Section

    Sponsor: Menoufia University. Phase: NA. Conditions: Chronic Post Cesarean Pain

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07545538: Carbohydrate Loading in Lowering Perioperative Insulin Resistance in Pediatric Surgery

    Sponsor: Gadjah Mada University. Phase: NA. Conditions: Insulin Resistance

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06299748: A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

    Sponsor: argenx. Phase: . Conditions: Myasthenia Gravis, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03625648: Pentoxifylline in Diabetic Kidney Disease

    Sponsor: VA Office of Research and Development. Phase: PHASE4. Conditions: Diabetic Kidney Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07495748: Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma

    Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Melasma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07179848: Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders

    Sponsor: Taipei Veterans General Hospital, Taiwan. Phase: PHASE1. Conditions: Health Adults, Temporal Interference Stimulation, Safety and Effectiveness, Crossover Study

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07560878: Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

    Sponsor: Mclean Hospital. Phase: EARLY_PHASE1. Conditions: Major Depression

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07397078: Clinical Accuracy Validation of the Moni-Patch Temperature Monitoring Patch System

    Sponsor: Murata Vios, Inc.. Phase: NA. Conditions: Body Temperature, Febrile

    full page →ctgov ↗
    ← prev
    page 98 of 110
    next →